Spartina Biotechnologies is an early stage biotech company that is developing and implementing a platform (SIREN™) for precision delivery of RNA molecules to specific cells and organs, beginning with RNAi molecules to destroy the SARS-CoV-2 virus genome. By its nature, SIREN will deliver natural-like RNA molecules to all the organs that SARS-CoV-2 is able to infect and precisely destroy the virus’s RNA without affecting any human gene’s RNA, blocking further replication and spread of the virus. The SIREN™ platform is poised to rapidly deploy to treat any emerging virus within a few months after discovery. SIREN™ can also treat numerous human diseases by silencing deleterious genes, thereby accelerating the RNA therapeutics industry.